Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Clare T. Atherton"'
Autor:
Robin C. Spiller, P. Elaine Blackshaw, Richard John Dansereau, Clare T. Atherton, Simon C. Lawes, Peter D. Hay, Leigh K. Wagner, Alan C. Perkins, Dan Schnell
Publikováno v:
Clinical Therapeutics. 30:834-844
Background: Delayed esophageal transit or disintegration of oral bisphosphonate tablets before they enter the stomach may be of concern with respect to iatrogenic complications among patients receiving longterm treatment. Different formulations of ge
Autor:
James R. Bebb, Joanne L. Brough, Janice Branson, Diane J. Stevenson, Johanne Bonner, Christopher J. Hawkey, Graham Scott, Brian C. McKaig, Jake Burdsall, John Jones, Rob Cunliffe, Christiane Rordorf, Clare T. Atherton
Publikováno v:
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2(2)
Lumiracoxib is a structurally novel, acidic selective inhibitor of cyclooxygenase (COX)-2. We coordinated existing methodologies in a single study to evaluate potency, selectivity, and effect on the human gastrointestinal tract.Twenty four healthy su
Autor:
Christopher J. Hawkey, John Jones, Clare T. Atherton, James R. Bebb, I T Bjarnason, Pär Karlsson, Urban Fagerholm, Bror Jonzon, Maeve M Skelly
Cyclooxygenase inhibiting nitric oxide donators (CINODs) are a new class of anti-inflammatory and analgesic drugs that may minimise gastrointestinal toxicity compared with standard non-steroidal anti-inflammatory drugs (NSAIDs) by virtue of nitric ox
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c06777317c31384168d78a0d49b665a
https://europepmc.org/articles/PMC1773862/
https://europepmc.org/articles/PMC1773862/
Autor:
Keith Gottesdiener, Christopher J. Hawkey, Josee Cote, Peggy H. Wong, S. U. E. Novak, Nicole Calder, Nigel M. Garlick, Amy Dallob, Nicholas J. Wight, Barry J. Gertz, Clare T. Atherton
Publikováno v:
Gastroenterology. 120(4)
Background & Aims: Rofecoxib, an inhibitor of the inducible cyclooxygenase (COX)-2 enzyme, appears not to cause acute gastroduodenal injury or chronic ulceration. To attribute this to COX-2 selectivity with sparing of gastric mucosal prostaglandin sy
Autor:
Nigel P. Shankley, Christopher J. Hawkey, Clare T. Atherton, James R. Bebb, Abed M. Zaitoun, Julie A. Smith, Richard A. Jones, Andy Rose, Nathalie Bailey-Filtter, Martin W. James
Publikováno v:
Gastroenterology. 124:A512-A513
Autor:
Howard Curtis, Clare T. Atherton, W. A. Stack, Nick J. Wight, John Jones, Lorin K. Johnson, Pamela Doty, Christopher J. Hawkey, Shri Pathmakanthan
Publikováno v:
Gastroenterology. 118:A1224-A1225
Autor:
Richard A. Jones, Clare T. Atherton, James R. Bebb, Nigel P. Shankley, Julie A. Smith, Christopher J. Hawkey, Nathalie Bailey-Flitter, Abed M. Zaitoun, Andy Rose, Martin W. James
Publikováno v:
Gastroenterology. 124:A175
Autor:
Nigel P. Shankley, Christopher J. Hawkey, Nathalie Bailey-Flitter, Richard A. Jones, Martin W. James, Julie A. Smith, Abed M. Zaitoun, Andy Rose, Clare T. Atherton, James R. Bebb
Publikováno v:
Gastroenterology. 124:A295
Autor:
Natalie Bailey-Fliter, Christopher J. Hawkey, Clare T. Atherton, James R. Bebb, Martin W. James, Abed M. Zaitoun
Publikováno v:
Gastroenterology. 124:A512
Autor:
Clare T. Atherton, John Jones, Christopher J. Hawkey, W. A. Stack, Colin Stott, M. Stevens, Shri Pathmakanthan, Howard Curtis, Nick J. Wight, P. Rubin
Publikováno v:
Gastroenterology. 118:A1324